Seer (SEER) Return on Sales Growth (3y) (2023 - 2026)

Seer (SEER) Return on Sales Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -76.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 8.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -1.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 3.00
10 Seer 230.63 Mn 230.63 Mn 1.51 Mn 10.00

Historic Data

Download Data
DateValue
Jun 30, 2026 10.00
Mar 31, 2026 10.00
Dec 31, 2025 1.00
Sep 30, 2025 4.00
Jun 30, 2025 3.00
Mar 31, 2025 15.00
Dec 31, 2024 1.00
Sep 30, 2024 17.00
Jun 30, 2024 8.00
Mar 31, 2024 289.00
Dec 31, 2023 34.00
Sep 30, 2023 100.00
Jun 30, 2023 79.00
Mar 31, 2023 15.00